saplin

Compare funds

UTI Value vs Nippon India Value

Both are value fund funds. Over the last 3 years UTI Value returned 13.4% a year and Nippon India Value 13.4%, against a category median of 13.4%. UTI Value costs 1.34% a year and Nippon India Value 1.24%. On the saplin Score UTI Value rates 7.0 (Neutral) and Nippon India Value 6.8 (Neutral) within their category. 42.8% of their money is in the same stocks.

Direct plans, growth option. Returns and risk as of 15 Nov 2026; past performance does not tell you future returns. See both side by side with charts.

At a glance

UTI ValueNippon India ValueCategory median
saplin Score (0–10)7.0 Neutral6.8 Neutral—
1-year return-1.3%-3.9%1.0%
3-year return, a year13.4%13.4%13.4%
5-year return, a year11.1%12.6%13.0%
Volatility (standard deviation)15.4%16.8%15.8%
Sharpe ratio0.490.470.49
Beta0.941.030.96
Upside capture99106100
Downside capture9410595
Expense ratio (Direct)1.34%1.24%1.17%
Fund size₹9,537 cr₹8,976 cr₹1,804 cr
Number of holdings638862
Top 10 holdings, share of fund42.8%37.1%37.9%
Portfolio P/E20.722.520.7
Lead managerAmit Premchandani (5 yrs)Dhrumil Shah (4 yrs)—
Launched20 Jul 20058 Jun 2005—

Green marks the higher return, Sharpe ratio, upside capture and Score, and the lower volatility, downside capture and cost. That is the direction of each measure, not a recommendation.

Portfolio overlap

UTI Value and Nippon India Value have 42.8% of their portfolios in the same stocks (23 holdings in common, portfolios as of 31 Oct 2026). Overlap is the smaller of the two weights in each shared holding, added up: 100% would be identical portfolios.

Biggest shared holdingsUTI ValueNippon India Value
HDFC Bank7.83%7.16%
Kotak Mahindra Bank4.52%4.63%
Axis Bank3.93%3.90%
ICICI Bank6.66%3.49%
State Bank of India3.32%3.93%
Bharti Airtel4.78%2.69%
Reliance Industries2.40%2.72%
Infosys3.56%1.91%
Larsen & Toubro1.72%2.16%
IndusInd Bank1.61%2.58%

The funds

How the Score works: methodology. Check any set of funds with the overlap checker.

More comparisons

saplin is not registered with SEBI. This page compares published data and is not a recommendation to buy, hold or sell either fund.